FindTrial
Sign In

Stent placement in Obstructive Colorectal Cancer Changing Blood and Tissue Biomarkers

The change on tumor biology after stenting in patients with malignant bowel obstruction of colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000835
Enrollment
20
Registered
2013-09-05
Start date
2013-09-02
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Gachon University Gil Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age > 20 years 2. Patients with malignant colorectal obstruction 3. Overt symptom and sign 4. Endoscopic stenting 5. Obtained informed concent and aggrement from patients after adequate explanation

Exclusion criteria

Exclusion criteria: 1. Bleeding tendency 2. Uncontrolled systemic disease 3. Pregnant or lactating women 4. Age < 20 years 5. Patients who refuse or who is unable to give informed consent on tissue sampling for the study

Design outcomes

Primary

MeasureTime frame
ischemia associated markers (such as HIF), epithelial-mesenchymal transition associated markers (such as E-cadherin, snail, twist, vimentin)—

Secondary

MeasureTime frame
Baseline characteristics (age, gender, tumor location, laboratory findings), complication, hospital stay, time of operation, etc—

Countries

Korea, Republic of

Contacts

Public ContactJung Ho Kim

Gachon University Gil Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026